Table of Contents
PharmSights
| PUMA Kills Stem Cells to Stall Cancer? |
Abstract PDF |
| Jian Yu |
112-118 |
| Transgenic Humanized AHR Mouse Reveals Differences between Human and Mouse AHR Ligand Selectivity |
Abstract PDF |
| Colin A. Flaveny, Gary H. Perdew |
119-123 |
| Developing Antiepileptogenic Drugs for Acquired Epilepsy: Targeting the Mammalian Target of Rapamycin (mTOR) Pathway |
Abstract PDF |
| Ling-Hui Zeng, Nicholas R. Rensing, Michael Wong |
124-129 |
Research Articles
| Nucleolin Binds to the Proliferating Cell Nuclear Antigen and Inhibits Nucleotide Excision Repair |
Abstract PDF |
| Chonglin Yang, Myoung Sook Kim, Devulapalli Chakravarty, Fred E. Indig, France Carrier |
130-137 |
| Extraction, Characterization, Stability and Biological Activity of Flavonoids Isolated from Chamomile Flowers |
Abstract PDF |
| Janmejai K. Srivastava, Sanjay Gupta |
138-147 |
Reviews
| RanGTPase: A Key Regulator of Nucleocytoplasmic Trafficking |
Abstract PDF |
| Ki Lui, Ying Huang |
148-156 |
| The Regulation of YY1 in Tumorigenesis and its Targeting Potential in Cancer Therapy |
Abstract PDF |
| Guangchao Sui |
157-176 |
FDA Corner
| FDA Approves New Drug Treatment for Type 2 Diabetes |
Abstract PDF |
| |
177 |
| FDA Approves First Maintenance Drug Therapy for Advanced Lung Cancer |
Abstract PDF |
| |
177 |
| FDA Approves Multaq to Treat Heart Rhythm Disorder |
Abstract PDF |
| |
178 |
| FDA Approves Drug for Treatment of Aggressive Brain Cancer |
Abstract PDF |
| |
178-179 |
LumiText Publishing, P.O. Box 774, Ellicott City, MD 21041
Copyright © 2008 LumiText Publishing. All rights reserved.
